Multiple Myeloma Hub cover image

Which patients might benefit the most from isatuximab-based combinations in the relapsed setting?

Multiple Myeloma Hub

00:00

Exploring the Efficacy of Isatuximab-Based Combinations in Relapsed Multiple Myeloma

Exploring the efficacy and benefits of Isatuximab in combination with carfilzomib and dexamethasone for treating multiple myeloma patients refractory to lenalidomide-based therapy, emphasizing the role of immunomodulatory agents in improving outcomes.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app